State-selective inhibition of alpha-synuclein aggregation by de novo oligomer-binding proteins
Yunxuan Zhang, Hannah L. Han, Lei Ortigosa-Pascual…·Tuomas P. J. Knowles
This study designs de novo proteins that selectively inhibit alpha-synuclein aggregation by targeting specific intermediates, with one binder preferentially inhibiting oligomer formation and secondary nucleation.